Sanofi lifts expectations for 2026 sales growth, looks to M&A

1

By Bhanvi Satija LONDON, Oct 30 (Reuters) – French drugmaker Sanofi said on Friday it expects sales to grow by a "low-teens percentage" this year, up from a previous forecast of 10% sales growth,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)